HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Commentary on an article by Jacob S. Vandermeer et al.: "Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head. A combined therapy that stimulates bone formation and decreases femoral head deformity".

AuthorsKeith M Baumgarten
JournalThe Journal of bone and joint surgery. American volume (J Bone Joint Surg Am) Vol. 93 Issue 10 Pg. e57 (May 18 2011) ISSN: 1535-1386 [Electronic] United States
PMID21593363 (Publication Type: Journal Article, Comment)
Chemical References
  • Bone Density Conservation Agents
  • Bone Morphogenetic Protein 2
  • Diphosphonates
  • Ibandronic Acid
Topics
  • Animals
  • Bone Density Conservation Agents (therapeutic use)
  • Bone Morphogenetic Protein 2 (therapeutic use)
  • Diphosphonates (therapeutic use)
  • Femur Head Necrosis (drug therapy)
  • Humans
  • Ibandronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: